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Metabonomics/metabolomics is an important science for the understanding of biological systems and the predic-
tion of their behaviour, through the profiling of metabolites. Two technologies are routinely used in order to an-
alyse metabolite profiles in biological fluids: nuclear magnetic resonance (NMR) spectroscopy and mass
spectrometry (MS), the latter typically with hyphenation to a chromatography system such as liquid chromatog-
raphy (LC), in a configuration known as LC–MS.With both NMR andMS-based detection technologies, the iden-
tification of the metabolites in the biological sample remains a significant obstacle and bottleneck. This article
provides guidance on methods for metabolite identification in biological fluids using NMR spectroscopy, and is
illustrated with examples from recent studies on mice.
© 2016 Dona et al. Published by Elsevier B.V. on behalf of the Research Network of Computational and Structural
Biotechnology. This is an open access article under the CCBY license (http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
Metabonomics is defined as ‘the quantitative measurement of the
multiparametric metabolic response of living systems to pathophysio-
logical stimuli or genetic modification’ and is concerned with the
study of themetabolic response of organisms to disease, environmental
change or genetic modification [1]. The similar term metabolomics [2]
was defined later and is now used interchangeably. In contrast to the
interventional definition of metabonomics, metabolomics has an obser-
vational definitionwhich is difficult if not impossible to achieve: ‘a com-
prehensive analysis in which all the metabolites of a biological system
are identified and quantified’ [2]. In this work we will use the original
term throughout. Metabonomics has many areas of application includ-
ing biology and medicine [3] with new developments such as
pharmacometabonomics (the ability to predict drug responses prior to
drug dosing) and the more general area of predictive metabonomics,
emerging recently [4–7].
There are many stages to a well-designed metabonomics experi-
ment including: 1) definition of study aims and experimental design,
2) ethical approval of the study, 3) sample collection and storage,
4) sample preparation, 5) data acquisition, 6) data quality control,
7) spectroscopic data pre-processing (for NMR data this would include
zero-filling, apodisation, Fourier transform, phasing, baseline correction
and referencing), 8) statistical data pre-processing including peak align-
ment, scaling and normalisation, 9) statistical analysis of the data to in-
terrogate e.g. differences in metabolite profiles due to a drug treatment,
10) identification of the metabolites that are responsible for themetab-
olite profile differences, 11) biological/biochemical interpretation of the
role of those metabolites, including pathway analysis and 12) reporting
of results and deposition of the data.
Many of the metabonomics study elements above have excellent
literature reviews and references available to assist effective study
execution [8–20]. However, the identification of the key biomarkers
or metabolites that are responsible for discriminating between dif-
ferent groups in a study (Stage 10 above) is non-trivial for both NMR
[15,21–28] and MS-based [28–34] metabonomics experiments. This
guide aims to provide an insight into the methodologies that can be
used for NMR-based metabolite identification in the course of a
metabonomics project. It is assumed that the reader is familiar with
the basics of NMR spectroscopy: many excellent books on the topic
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are available [35–38]. The focus of this guide is on the use of 1HNMR, or
1H NMR-detected heteronuclear 2D NMR experiments, for metabolite
identification in metabonomics experiments on biological fluids.
2. Molecular structure information from 1D NMR spectra
of metabolites
A surprising amount of information is available from a one-
dimensional (1D) 1H NMR spectrum, including: 1) chemical shifts,
2) signal multiplicities, 3) homonuclear (1H - 1H) coupling constants,
4) heteronuclear coupling constants (typically 14N–1H or 31P–1H),
5) the first order or second-order nature of the signal, 6) the half band-
width of the signal, 7) the integral of the signal and 8) the stability of the
signal (changes in the integral with time). We will not cover: 9) spin–
lattice relaxation times (T1s) or 10) spin–spin relaxation times (T2s).
Whilst an appreciation of both these latter features is critical for the con-
duct of all NMR experiments, and differentiation of short from long T2s
is fundamental in the Carr–Purcell–Meiboom–Gill (CPMG) spin-echo
pulse sequence for plasma analysis, these features are of minor impor-
tance per se for metabolite identification. We will deal with each of
the first 8 features in turn and see how they can be used to assistmetab-
olite identification.
2.1. 1H NMR chemical shifts
Each chemically distinct hydrogen nucleus in each metabolite in a
biological sample, such as a biofluid, will exhibit an NMR signal at a
characteristic resonance frequency, which is measured as a chemical
shift relative to a standard compound. For example, in metabonomics
studies of urine, it is common to add a reference material such as 3-
(trimethylsilyl)-2,2′,3,3′-tetradeuteropropionic acid (usually abbreviat-
ed to TSP) or deuterated forms of 4,4-dimethyl-4-silapentane-1-
sulfonic acid (DSS) or its sodium salt, and define the chemical shift of
the TSP or DSS methyl resonances as 0 ppm. Our preference is to use
TSP as the reference material in biofluids without significant protein
concentrations. The normal reference material for NMR spectroscopy
in organic chemistry, tetramethylsilane (TMS) is rarely used in
metabonomics studies, as it is insoluble in aqueous solutions.
The exact chemical shift of theNMR signal of a hydrogen nucleus in a
metabolite is independent of the applied field strength, is highly repro-
ducible and precisely characteristic of that nucleus, in thatmetabolite, in
the particular matrix conditions. For biofluids such as blood plasma or
serum,where DSS or TSPmay becomebound tomacromolecule compo-
nents, it is common to reference the spectra to the H1’ anomeric proton
of the alpha anomer of glucose at 5.233 ppm, to avoid variation in refer-
ence intensity and position due to binding [39]. However, care must be
takenwith temperature control as this signal has high temperature sen-
sitivity and indeed, has been used as an NMR thermometer [40].
When comparing the experimental 1H NMR chemical shifts of hy-
drogens in metabolites in intact biofluids with those of the correspond-
ing pure reference standards in aqueous solution, it is usual for values to
agreewithin 0.03 ppm.One of the strengths of NMR spectroscopy is that
the chemical shifts are exquisitely sensitive to structural and environ-
mental change. Indeed, sensitivity of chemical shifts to pH change can
be used to distinguish or identify metabolites, especially those contain-
ing ionisable functional groups [41].Whilst this is an excellent feature in
termsof decreasing the likelihood of two similarmolecules having iden-
tical 1H NMR spectra, it does mean that for some metabolites, environ-
mental change can have a significant effect on the spectra, including
the 1H NMR chemical shifts. A classic case of this sensitivity to the envi-
ronment occurs for the diastereotopic methylene hydrogens in citric
acid. Changes in pH between sampleswill alter the ionisation of the car-
boxylate groups in citric acid and thus affect the chemical shifts of the
methylene hydrogens. In addition, it is well known [3] that citric acid
can chelate metal ions such as calcium, magnesium and sodium. Thus,
even if biofluid samples are buffered effectively to a constant pH,
changes in metal ion concentrations between samples, which are not
readily apparent by 1HNMR, may have a significant effect on the chem-
ical shifts and the half bandwidths of the signals of the methylene hy-
drogens of citric acid and also any other metabolites with similar
properties. This effect is observed in Fig. 1.
Many general resources are available which correlate the relation-
ships between chemical structure and NMR chemical shifts [36,42], in-
cluding web resources [43], whilst more specific metabonomics-
focused databases are covered in Section 4.3 below. As for 13C NMR
chemical shifts (see Section 2.2 below), it is also possible to calculate
1H NMR shifts, especially in discrete series [43].
2.2. 13C NMR chemical shifts
Most metabonomics experiments are conducted with 1H NMR de-
tection. However, the 2D 13C, 1H HSQC NMR (Section 3.5 below) and
2D 13C, 1H HMBC NMR (Section 3.6) experiments which correlate 1H
NMR chemical shifts with 13C NMR chemical shifts over 1-bond
(HSQC) or 2 to 3 bonds (HMBC) are very important formetabolite iden-
tification, as they enable the determination of the 13C NMR chemical
shifts of metabolites, so an appreciation of the nature of 13C NMR chem-
ical shifts is required. One key feature of 13CNMR chemical shifts is their
much larger range of values comparedwith 1HNMR chemical shifts. For
common metabolites 13C NMR chemical shifts occupy a huge range of
values from ca 10 ppm for methyl carbons such as C4 in butanone to
ca 222 ppm for the ketone (C2) carbon in the same molecule. Thus the
range of 13C NMR chemical shifts is ca 20 times that of 1H NMR and
this is the reason that their measurement is so important in metabolite
identification: they are much more sensitive to small changes, or more
remote changes in molecular structure, including stereoisomerism,
than 1H NMR chemical shifts.
For simple molecules 13C NMR chemical shifts can be calculated
by hand using simple additivity tables.[44] For example in
simple substituted benzenes such as para-cresol (1-hydroxy-4-
methylbenzene), the 13C NMR chemical shifts of all of the carbons
can be calculated by adding the known substituent effects of hy-
droxyl and methyl groups [44] to the chemical shift of benzene in
an additive fashion.
The substituent parameters for an hydroxyl group added to a ben-
zene ring are +26.9 (ipso), −12.7 (ortho), +1.4 (meta) and
−7.3 ppm (para position). For a methyl group the corresponding pa-
rameters are +9.3 (ipso), +0.8 (ortho), 0.0 (meta) and −2.9 ppm
(para) [44]. The accepted 13C NMR chemical shift of benzene is
128.5 ppm. Even if themolecule para-cresol was not in ametabolite da-
tabase, we could calculate the 13C NMR shifts with some degree of pre-
cision. For C2 and C3 the calculated shifts would be as follows:
δC2 ¼ 128:5–12:7 OH orthoð Þ þ 0 methyl;metað Þ ¼ 115:8 ppm
δC3 ¼ 128:5þ 1:4 OHmetað Þ þ 0:8 methyl; orthoð Þ ¼ 130:7 ppm
For comparison, the actual values in the HMDB [45] for para-cresol,
HMDB01858, in water at pH 7.0 are 117.9 and 132.8 ppm for C2
and C3 respectively. Modern NMR data processing software such
as MNova [46] possesses more sophisticated 1H, 13C, and multinuclear
NMR chemical shift calculation and prediction algorithms. The
136 A.C. Dona et al. / Computational and Structural Biotechnology Journal 14 (2016) 135–153
algorithm in MNova 10.0.0 predicted shifts of 117.6 and 130.0 ppm for
C2 and C3 respectively, a very good fit to the real data for C2, but not
quite as good as the simple hand calculation for C3. MarvinSketch v
6.1.1 from ChemAxon [47] also has 1H and 13C NMR chemical shift cal-
culation capabilities and it gave 115.3 and 130.0 ppm for C2 and C3 re-
spectively. Calculations such as these can be useful when information
aboutmetabolites of interest is not in the existing databases: a common
occurrence. However, users must be aware that these calculations are
approximate, with precision varying according to the complexity of
the metabolite and the relationship of the structure of the metabolite
to the molecules in the prediction calculation database, or to those
used to derive the substituent tables. In general a precision of better
than +/−5 ppm is usually achieved for 13C resonances.
It is beyond the scope of this guide to discuss factors that influence
13C NMR shifts in any detail. However, the key factors include:
hybridisation of the carbon atom (sp3, sp2 or sp. hybridised), inductive
substituent effects and mesomeric effects [43,48–52].
2.3. 1H NMR multiplicities
The multiplicity is the pattern of peaks that is observed for a partic-
ular hydrogen signal in the 1H NMR spectrum. In a first order 1H NMR
spectrum, the frequency difference between the resonances of coupled
hydrogens is large (≫10 times) relative to the value of the coupling con-
stant between them. In those circumstances, the signals exhibit first
order coupling patterns, which obey an n + 1 splitting rule, where n
is the number of equivalent coupling partners. For instance, methyl
groups such as those of lactic acid which couple with one hydrogen on
an adjacent carbon via a homonuclear, 3-bond vicinal coupling, 3JH,H,
will be split into a doublet signal (1+ 1= 2). Correspondingly, the sig-
nal of the lactate methyne CH proton will be split into a 4-line quartet
due to the interaction with the 3 equivalent methyl hydrogens
(3 + 1 = 4). The intensity ratios of these multiplet signals follow
Pascal's triangle [35], being 1:1, 1:2:1, and 1:3:3:1 for a doublet, triplet
and quartet respectively. An example of a 1:2:1 triplet from one of the
methylene CH2 groups in 2-oxoglutaric acid is clearly observed at
2.45 ppm in the 1H NMR spectra of the urines of the mice in Fig. 1.
If a particular hydrogen is coupled tomore than one group of hydro-
gens, then more complex coupling patterns or multiplicities are
observed. For instance, the CH2–3 methylene signal from the butyryl
chain of N-butyrylglycine resonates as a triplet of quartets as it is
coupled to both the terminal CH3–4 protons and the CH2–2 protons ad-
jacent to the C1 amide carbon. If the coupling constants involved were
non-equal then up to 12 lines could be observed (4 × 3). However, in
this case, the CH3–4 to CH2–3 coupling constant (7.4 Hz) is almost
equal to the CH2–2 to CH2–3 coupling constant (7.5 Hz) and the C3
methylene signal resonates as a pseudo-sextet due to signal overlap
(Fig. 2).
The analysis of signal multiplicities, simple and complex [36,43], is
important for the identification of metabolites. Multiplicity-editing
spin-echo NMR experiments can also be used to distinguish between
signalswith differentmultiplicities and this can be helpful inmetabolite
identification. A good example is the use of spin-echo 1H NMR in the
identification of novel penicillin metabolites, where the characteristic
singlet signals of the penicillin gem-dimethyl groups can be easily iden-
tified by Hahn spin-echo methods [53,54]. Many spectra do not obey
first order requirements however and two main consequences arise
from this; multiplicity intensities may be distorted, or in extreme
cases additional linesmay occur in themultiplets: see Section 2.6 below.
2.4. Homonuclear 1H, 1H coupling
Scalar coupling can occur between all non-equivalent hydrogen
atoms in a metabolite. The key requirement here is magnetic non-
equivalence. Hydrogens that are equivalent by molecular symmetry,
such as the methyne hydrogens in tartaric acid, or equivalent by virtue
of fast rotation, such as those of methyl hydrogens, will not show scalar
coupling between themselves. Indeed the two methyne hydrogens of
2R, 3R-tartaric acid resonate as a characteristic, sharp singlet at
4.34 ppm in urine.
Fig. 1. an expansion of the 600 MHz 1H NMR spectrum of the urine of four, 30-week-old, male C57BL/6 mice, in the region of the doublet signals of citrate at ca 2.70 and 2.56 ppm. Even
though the urine is buffered to pH 7.4, there are differences in the chemical shifts of the citrate signals between the four urine samples and noticeable differences also in half bandwidth,
with the signals of mouse 1 (bottom spectrum) being especially broadened. The ‘roofing’ of the doublet citrate signals towards one another is illustrated by the arrows above the citrate
resonances of mouse 4. See Section 2.6 on 2nd order effects.
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The detection of the presence of scalar coupling between two hydro-
gens in a metabolite is very important in metabolite identification, as
the magnitudes of the coupling constants are characteristic of the elec-
tronic pathway between the two hydrogens or groups of hydrogens.
Scalar coupling is transmitted via the bonding electrons in the metabo-
lites and drops off in magnitude as the number of bonds between the
hydrogens increases. Most of the homonuclear scalar couplings ob-
served in metabolites will be two-bond geminal couplings (2JH,H) be-
tween hydrogens on the same carbon, or three-bond, vicinal couplings
(3JH,H) between hydrogens on adjacent carbons in a metabolite. In gen-
eral, 2-bond geminal couplings are larger in magnitude than 3-bond,
vicinal couplings. However, geminal couplings are affected by the
hybridisation of the carbon atom and by the electronegativity of substit-
uents, and in some alkenes, such as R1R2C =_CH2 the
2JH,H value for
the terminal =_CH2 will be close to 0 Hz. In passing, we should note
that most geminal couplings are negative in sign and most vicinal cou-
plings are positive, but this is not relevant for most analyses and we
will ignore this feature henceforth. The largemagnitude of geminal cou-
plings in sp3CH2 groups is well illustrated by the spectrum of citrate
shown in Fig. 1, where the geminal 2JH,H coupling is ca 16.2 Hz. By con-
trast, the 3-bond, vicinal coupling between the C3–CH2 group and its ad-
jacent methyl and methylene group neighbours in N-butyrylglycine is
ca 7.4 and 7.5 Hz respectively (Fig. 2). These 3JH,H values are smaller
and are typical of the values for free-rotating aliphatic moieties.
The values of vicinal couplings are particularly sensitive to stereo-
chemistry in relatively rigid systems and this is well illustrated by me-
tabolites such as D-glucose, which exists as two anomers in slow
exchange with one another, so that separate signals are observed for
each anomer.
The anomeric proton at C1 in the alpha anomer is in an equatorial
position on the 6-membered pyranose ring and has a modest 3JH,H cou-
pling of ca 3.7 Hz to the axial H-2 (equatorial–axial coupling). By
contrast, the coupling between H2 and H3 (both axial) has a value
3JH,H ca 9.8 Hz because this is a favoured, di-axial coupling. Thus the
magnitude of coupling constants can give information on the type of
coupling and the stereochemistry of the interacting hydrogens. In addi-
tion to this, the values of coupling constants are affected by the electro-
negativity of groups in their vicinity, due to their impact on the
electrons that transmit the coupling [43].
If 1H NMR spectra are acquired with good spectral resolution,
good digital resolution and good lineshape, it is possible to observe
4-bond, 5-bond and even 6-bond hydrogen-to-hydrogen cou-
plings, 4JH,H,
5JH,H and
6JH,H, in biofluids. For example, in cis-
aconitic acid, it is usual to observe the olefinic proton at ca 5.74 as
a triplet with 4JH,H ca 1.4 Hz due to long-range, 4-bond coupling
to the equivalent methylene CH2 hydrogens across the double
bond (Fig. 3).
In the trans-aconitic acid isomer, the olefinic proton at 6.60 ppm is a
triplet with a smaller 4JH,H ca 0.8 Hz coupling. Note the enormous sensi-
tivity of the chemical shift to the geometry of the double bond: the ole-
finic proton shifts nearly 0.9 ppm just from the change of double-bond
geometry, and the change in the coupling value for 4JH,H is also
diagnostic.
2.5. Heteronuclear 1H, X coupling
These couplings are less common but will occur in phosphorous-
containing metabolites such as adenosine monophosphate, where the
presence of the NMR-active, 100% abundant, spin I = 1/2, 31P isotope
will give rise to additional 3-bond and 4-bond 3JP,H and
4JP,H couplings
to the ribose ring protons, that are highly diagnostic [55]. Another
less-commonly observed heteronuclear coupling in metabolites is due
to the 99.6% natural abundance 14N isotope which is NMR-active but
quadrupolar, with spin quantum number I = 1. Due to quadrupolar re-
laxation, couplings to 14N are not often observed, but in a symmetrical
environment, the effects of quadrupolar relaxation are reduced and
small couplings may be observed and these can also be critical for me-
tabolite identification. For instance, in choline (HMDB00097), the
almost symmetrical environment around the nitrogen allows the obser-
vation of a small 2JN,H coupling of ca 0.6 Hz (1:1:1 triplet due to spin
quantum number I = 1) to the methyl hydrogens due to 2-bond cou-
pling to the 14N. So, in this unusual case, the methyl signal is a narrow
triplet instead of the expected singlet (Fig. 4).
Fig. 2.An expansion of the 600MHz 1HNMR spectrumof the urine of amale, 15-week-old, C57BL/6mouse, in the region of the signal from the CH2–3methyleneprotons ofN-butyrylglycine
at ca 1.62 ppm (dots). This pseudo-sextet signal is actually a triplet of quartets with the two 3JH,H couplings being almost equal in magnitude (7.4 and 7.5 Hz) resulting in overlap of many of
the lines. The molecular structure of the metabolite is superimposed.
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2.6. Second-order effects and strong coupling in 1H NMR spectra
As the frequency separation in Hertz between coupled 1H NMR sig-
nals decreases to less that ca 10 times the value of the coupling constant
between them, distortions to expected multiplet peak intensities start to
occur in the spectra. The spins are said to exhibit ‘strong coupling’, or to
be in a second-order system. The spectra take on appearances that are dif-
ferent from those of systems that exhibit ‘weak coupling’ or are in first-
order systems. Rather than being aproblem, this is actually an aid to spec-
tral interpretation andmetabolite identification, as follows. In the simple
case of two, non-equivalent hydrogen atoms coupling with one another,
the intensity distortion is such that the doublets slope towards one an-
other in an effect called ‘roofing’. This is well illustrated in the spectra of
the two, non-equivalent methylene protons in citric acid shown in
Fig. 1. The chemical shift difference between the resonances at 2.70 and
2.56 ppm is 0.14 ppm, which equates to ca 84 Hz at 600 MHz operating
frequency. The 2JH,H coupling is ca 16.2 Hz and therefore the ratio of the
frequency separation to the coupling constant is 84/16.2 = 5.2. This
two-hydrogen spin system is formally designated AB: the two letters in-
dicate that there are two distinct spins or hydrogen atoms involved in the
coupling system; the closeness of the letters in the alphabet indicates that
their chemical shifts are close in frequency. The roofing of the signals is
clear to see in Fig. 1 and provides a way, without using 2D COSY NMR
or any decoupling techniques, to determine that these hydrogens are
coupled to one another; an important and often overlooked benefit of
this feature. In a two-spin system that is first order, the nomenclature
would be AX instead of AB to indicate that the two hydrogens are widely
separated in chemical shifts, relative to the size of their mutual coupling.
Fig. 3.Anexpansion of the 600MHz 1HNMR spectrumof theurine of pooled,male C57BL/6mice at 15weeks of age, in the region of the signal from the olefinic proton of cis-aconitic acid at
ca 5.74 ppm. The signal is a triplet due to a long-range, 4-bond, 4JH,H coupling of ca 1.4 Hz to the two equivalentmethylene hydrogens. The 1:2:1 nature of the triplet is clear, even though it
is superimposed upon the very broad signal from urea at ca 5.80 ppm.
Fig. 4.Anexpansion of the 600MHz 1HNMR spectrumof the pooledurine ofmale C57BL/6mice at 15weeks of age, in the region of the signal from themethyl protons of choline (structure
superimposed) at ca 3.20 ppm. The signal is a 1:1:1 triplet (dots) due to a 2-bond coupling of ca 0.6 Hz to the 14N nucleus. Interestingly, thewell-resolved doublet at ca 3.13 ppm is due to
the methylene protons of cis-aconitic acid with 4JH,H coupling of ca 1.4 Hz (see also Fig. 3). The spectrum has been zero filled to 131,072 points and resolution enhanced by Gaussian
multiplication, prior to Fourier transformation.
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If the spin system is more complex, or the ratio of signal frequency
separation to coupling constant becomes much smaller, the intensity
distortions can becomemore significant and in extreme cases involving
three spins or more, additional lines are seen in the resonances which
are not always interpretable by first order analysis. This effect is
commonly observed in the NMR signals for the aromatic hydrogens in
symmetrically substituted benzene rings (Fig. 5).
For metabolites such as para-cresol sulphate, the phenomenon of
magnetic non-equivalence appears [37]. The hydrogens on C2 and C6
are chemically equivalent by symmetry, as are those on C3 and C5.
Fig. 5. Two versions of the 600MHz 1H NMR spectrum of an authentic sample of the metabolite para-cresol sulphate in deuterated phosphate buffer at pH 7.4, in the region of the signals
from the aromatic hydrogens: 1) with a standard 0.3 Hz line-broadening and 2) resolution-enhanced using a Lorentzian to Gaussian transformation. The signal of the H2, H6 protons ap-
pears as a complex, second-ordermultiplet at ca 7.22 ppm, instead of afirst-order doublet. The signal of theH3, H5protons at ca 7.29 ppmdisplays additional complexity due to coupling to
the methyl protons via a 4-bond coupling, in addition to the extra lines, clearly visible in this second-order system.
Fig. 6. 1) The 600 MHz 1H NMR spectrum of the urine of a 30-week-old, male, flavin mono-oxygenase 5 (FMO5) knockout mouse [61] in the region of the aromatic signals from hippuric
acid (structure inset). The spectrum is resolution enhanced by Gaussian multiplication. 2) A spin simulation of the aromatic signals from hippuric acid using the MNova spin simulation
function. A good approximation to the complex, second-order signals was obtained. The complexity of the two ortho and two meta hydrogen signals is due to the fact that whilst
these hydrogens are chemically equivalent (within each pair), they are magnetically non-equivalent and are part of a five hydrogen AA’BB’M spin system (see Section 2.6). Signals
from 3-indoxyl sulphate and other metabolites are present in the real spectrum (1).
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However, these pairs of hydrogens are NOT magnetically equivalent.
The reason for this is as follows: H2 is ortho to H3 and has a 3-bond cou-
pling to it. By contrast, the chemically equivalent proton H6 is ortho to
H5 and para to H3. Thus, in terms of their nuclearmagnetic interactions,
these hydrogens are non-equivalent and this has consequences. The fre-
quencydifference between the signals of H2 andH6 is 0Hz by definition
and they are coupled by a favourable, long-range ‘W’ coupling over 4-
bonds. Thus, the frequency separation to coupling ratio is 0, no matter
what the value of the coupling constant and the resultant spectra are
second-order [37]. This spin system is designated AA’BB’, where A and
A’ representH2 andH6 and the apostrophe signifies a chemically equiv-
alent but magnetically non-equivalent nucleus. B and B’ are H3 and H5
and the closeness of the letters in the alphabet is deliberate and signifies
the closeness of the chemical shifts of these two groups of spins. In these
extreme cases, additional lines appear in the spectra and the resonance
patternsmay not be readily interpretable by first order analysis. Instead
of a simple pair of doublets, asmight be expected, a complex pattern ap-
pears (Fig. 5). Typically, a computational, spin simulation program is
used to calculate the spectrum and this is now a routine procedure. An
important point to appreciate is that it may not be straightforward to
extract chemical shifts or coupling constants from second-order spectra
without spin simulation: see Section 2.10 and Fig. 6.
2.7. The half bandwidth of NMR signals
Another feature that provides information on the structure and the
dynamics of metabolites is the half bandwidth of their signals. The
half bandwidth, Δν1/2 of a signal is related to the real spin–spin relaxa-
tion time of the hydrogen giving rise to that signal according to Eq. (1):
Δν1=2 ¼ 1=π:T2 ð1Þ
... where T2* is the real spin–spin relaxation time that takes into account
underlying molecular relaxation processes, plus the effect of field inho-
mogeneities and the influence of factors such as the presence of para-
magnetic species (including dissolved oxygen gas) in the sample. T2*
can be shortened by interaction with quadrupolar spins, such as 14N
and by chemical exchange. In the case of chemical exchange between
two forms of a metabolite, A and B, the lifetime of a spin in species A
is necessarily limited to the lifetime of species A, as a maximum.
Exchange-broadening of the signals will occur when the exchange
rate in Hertz between forms A and B is of the same magnitude as the
chemical shift difference in Hertz between the corresponding hydro-
gens in A and B. The broadening effects of exchangewithwater, quadru-
polar relaxation and unresolved couplings to 14N can be quite large, as
can be seen in Fig. 3, where the hydrogen signal from urea has a half
bandwidth of ca 50 Hz, in contrast to the much narrower linewidth of
the olefinic proton in cis-aconitic acid, where all of these effects are ab-
sent and consequently the non-exchanging hydrogens have much larg-
er T2* values.
2.8. The integral of NMR signals
When NMR experiments are run with sufficient delay times in be-
tween the acquisition of each successive free induction decay, the nuclei
under observation will enjoy close to full spin–lattice relaxation. Under
these conditions, the signals will not be partially saturated [35], and the
area of amethyl (CH3) signal in ametabolite in a biofluidwill be precise-
ly three times that of a methyne (CH) signal in the same metabolite in
the same sample. NMR spectroscopy is thus an inherently quantitative
technique and this is a huge advantage for the conduct ofmetabonomics
experiments. It should be noted however that most NMR-based meta-
bolic profiling experiments do not achieve full relaxation with the
delay times typically used. Even so, the situation is in stark contrast to
MS-based profiling, where the intensities of signals from metabolites
may be significantly suppressed or enhanced by the presence of other
metabolites in the sample [56] and internal reference standards are re-
quired in order to achieve quantitation.
Quantifying the level of a metabolite in a biological fluid such as
urine, by 1HNMR spectroscopy, can be very difficult, because of spectral
crowding and spectral overlap, and great care is required either with
line fitting or direct integration quantification approaches. However,
when careful approaches are taken, the analytical precision of themeth-
odology is high [12,57,58] and this is critical for the statistical analysis of
the data and the reliable discovery of discriminating biomarkers: see
Section 4.1.
2.9. The stability of NMR signals
Generally, the metabolic profile of a biological fluid is stable over a
significant period of time at room temperature, and certainly stable
enough for the acquisition of routine 1D and 2D 1HNMRdata. However,
there are exceptions. Some biological fluids are inherently unstable. A
good example of this is human seminal fluid, where, post-ejaculation,
enzymatic reactions take place that cause the biochemical transforma-
tion of some metabolites [59]. In addition, if a sample such as animal
urine, has been in contact with animal faeces at any stage, it will be mi-
crobiologically contaminated and potentially unstable. Bacterial growth
in a urine sample, for instance, will result in the transformation of cer-
tainmetabolites into newproducts, as the bacteria scavenge the biofluid
for fuel sources. It is common practice to add anti-bacterial agents such
as sodium azide [8,16] to inhibit the growth of the bacteria. However, in
our experience, even in the presence of sodium azide at 9 mM,
bacterially-mediated metabolite transformations can still occur in
mouse urine if kept at room temperature for extended periods, and
hence, signals will be unstable over time: the signals of fermentation
substrates will decrease, whereas those of products will increase. See
Section 4.6, Biochemical Transformation and In Vitro Fermentation of
Biofluids to Aid Metabolite Identification. A major improvement in this
area has occurred with the development of cooled sample changers,
such as the SampleJet system fromBruker Corporation (Billerica,Massa-
chusetts, USA), that keeps queued samples at 4 C prior to their insertion
into the NMR magnet, thus minimising sample instability.
2.10. Interpretation of 1D 1H NMR spectra and metabolite identification
Metabolites that are present at relatively high concentrations or that
have distinctive signals in relatively uncrowded spectral regions can be
identified by inspection from a simple 1D 1HNMR spectrum. This can be
done manually by the spectroscopist interpreting the data, or with the
assistance of software such as Chenomx NMR Suite (Chenomx, Edmon-
ton, Canada), which has the advantage of a database of standardmetab-
olite spectra at a variety of magnetic field strengths and a variety of pH
values [60]. Obvious metabolites include citric acid (see Fig. 1) where
the (somewhat variable) chemical shifts and large ‘roofed’ geminal cou-
plings of themethylene protons are unmistakeable. Another easily iden-
tifiable metabolite is hippuric acid, whose second-order aromatic
proton resonances between 7.9 and 7.4 ppm provide an unmistakable
‘fingerprint’ for identification (Fig. 6).
Certain other metabolites have distinctive singlet signals at charac-
teristic chemical shifts, such as the methyl hydrogens of methylamine,
dimethylamine and trimethylamine at ca 2.61, 2.73 and 2.88 ppm re-
spectively. However, little information is present in the 1D 1H NMR
spectrum of these metabolites: just one singlet resonance. Hence, it is
advisable to check the assignments of these types of resonances using
a 2D 13C, 1H HSQC experiment to verify that the methyl carbons have
the expected chemical shifts of ca 27.7, 37.6 and 47.6 respectively for
methylamine, dimethylamine and trimethylamine. Note the uniform
ca 10 ppm increase in methyl carbon chemical shift as each methyl
group is added, due to the additive, two-bond or beta substituent effect.
The identification of metabolites present at relatively low levels, or
that have signals that are partially or completely overlapped, will be
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difficult by 1D NMR methods and the use of two-dimensional NMR
spectroscopic methods is required. In Section 4.7, we will review how
much information is required in order to consider the identification of
a known metabolite confident.
3. Molecular structure information from two-dimensional (2D)
NMR spectroscopy
3.1. Introduction to 2D NMR spectroscopy
In a 1D NMR spectrum the NMR signals are acquired as a function of
a single time variable (t2) in a free induction decay (FID), typically over
65,536 data points at a 1H frequency of 600 MHz. This FID arises from
the induction of an electric current in the receiver coils of the NMR
probe by the excited nuclear magnetisations: there is no emission
event detected in NMR. Fourier transformation of this FID gives rise to
the conventional 1D 1H NMR spectrum in which NMR signal intensity
(y-axis) is plotted as a function of chemical shift (x-axis). By contrast
in a 2DNMRexperiment, a second timedimension (t1) is artificially cre-
ated by the deliberate incrementing of a time delay, known as the evo-
lution time, between two of the radiofrequency pulses in the pulse
sequence used. An FID is collected for each of m values of the evolution
time, such that at the end of the experiment, m x FIDs have been collect-
ed, each containing n data points. Double Fourier transformation of this
data set over both t2 and t1 results in a single 2D NMR spectrum in
which signal intensity (z-axis) is plotted as a function of two orthogonal
signal frequency axes; f2 and f1 corresponding to t2 and t1 in the time
domain (x and y respectively). The spectra are typically displayed as
contour plots where signal intensity is represented by contour lines, in
much the same way that the heights of mountains and hills are repre-
sented on maps.
We shall not go into the details of the design of the 2DNMRpulse se-
quences, nor the analysis of how those pulse sequences give the
resulting spectra, as many excellent reference works are available in
this area [35,37].
3.2. 2D 1H J-resolved (JRES) NMR spectroscopy
The 2D 1H J-ResolvedNMR Spectroscopy (JRES) experiment is one of
the simplest 2D NMR experiments and one of the most useful for the
analysis of the complex 1H NMR spectra of biological fluids [21,22,62].
The experimental radiofrequency pulse sequence is simply: RD - 900H
- t1/2 - 1800H - t1/2 - FID, where RD is a relaxation delay. The second
proton pulse (1800H) occurs in themiddle of the incremented evolution
time (t1). In the resulting 2D 1HNMR JRES spectrum, the chemical shifts
run along thefirst frequency dimension, f2, as normal, and homonuclear
coupling constants are modulated (spread out) across a second fre-
quency dimension, f1. For simple, first order spin systems, no new sig-
nals are created: the existing signals are just spread out across two
frequencydimensions instead of one. This has a tremendous effect in re-
ducing signal overlap in crowded spectral regions. The spectra are typi-
cally tilted by 450 so that all the signals of a homonuclear multiplet
appear at the exact same chemical shift. The projection of the 2D spec-
trum onto the chemical shift dimension, f2, is then effectively a broad-
band proton-decoupled proton NMR spectrum, in which each 1H
resonance is a singlet. It is important to note that heteronuclear cou-
plings are unaffected by the 1H1800 pulse in the 2D 1HNMR JRES exper-
iment and these are notmodulated across the second dimension of the
2D spectrum [55].
The tremendous improvement in signal resolution by spreading the
NMR signals out across a second dimension is clearly illustrated in Fig. 7.
In the 1D 1H NMR spectrum of the urine of an FMO5 knockout mouse
[61], the triplet methyl signal for N-butyrylglycine (three blue circles
at 0.926 ppm) is overlapped with the doublet methyl signal for
isovaleric acid (two red squares at 0.916 ppm). By contrast in the 2D
1H JRES NMR spectrum, these signals are completely resolved from
one another.
The simple interpretation of 2D 1H JRESNMR spectra only applies for
first order systems in which there is weak coupling. If strong coupling
exists (a second-order system) then artefacts can appear in the spectra
[63]. This occurs because in a strongly coupled system the second 1H
pulse (a 1800 or π pulse) will cause not just the modulation of the sig-
nals of a homonuclear-coupled spin across the second dimension, ac-
cording to the size of its spin couplings, it will also cause the mixing of
the transitions or signals between coupled spins, such aswould normal-
ly occur in a chemical shift correlation experiment such as COSY (via the
second 900 pulse). Thus, in a simple two hydrogen AB spin system such
as citric acid, the two A transitions (doublet) become mixed with the
two B transitions and in a tilted 2D 1H JRES NMR spectrum, signals ap-
pear in the 2D spectrum at chemical shifts where there are no hydro-
gens! It is very important to recognise these ‘artefacts’ in order to
avoidmis-assigning the spectra to non-existentmetaboliteswith unreal
J values! Fig. 8 shows an example of this feature for citric acid itself: the
2nd order signals in the 2D 1H JRES NMR spectra are marked with stars.
Awareness of the origin of these signals allows chemical shift corre-
lation information to be extracted from the 2D 1H JRES NMR spectrum,
so these artefacts can have real utility in spectral assignment and me-
tabolite structure elucidation!
An important use of 2D 1H JRES NMR spectra is to establish themag-
nitude of the coupling constants for the 1HNMR signals of particular hy-
drogen atoms. This can readily be done even when the metabolites are
at low levels and the signals are difficult to see in the 1D 1H NMR spec-
tra. For example, Fig. 9 shows an expansion from the 2D 1H JRES NMR
spectrum of the urine of an FMO5KOmouse at 30weeks of age. The sig-
nals at 2.003 and 1.845 are from the two methylene hydrogens at C3 in
2S-hydroxyglutaric acid (HMDB00694). The chemical shifts of the two
hydrogens are close to the values reported in the HMDB (1.985 and
1.825 respectively) but the assignment of the two hydrogens is much
more secure if the coupling constants can also be shown to match. In
this case the 1D 1H NMR FID of the authentic metabolite was
downloaded from the HMDB and reprocessed. This showed that the
line separations in the multiplets at 1.985 and 1.825 in the authentic
metabolite were identical to those observed at 2.005 and 1.845 in the
2D 1H JRES NMR spectrum of the urine of an FMO5 KO mouse at
30 weeks age, thus helping confirm this metabolite identification.
3.3. 2D 1H chemical shift correlation spectroscopy (COSY)
The 2D 1H chemical shift correlated spectroscopy (COSY) NMR ex-
periment is a workhorse of metabonomics analyses for the identifica-
tion of the metabolites in biological samples. Many variants of the 2D
1HCOSYNMRexperiment exist [35] but all variants provide information
onwhich hydrogens are spin–spin coupled together, and this is vital for
metabolite structure identification. The basic pulse sequence is: RD -
900H - t1 - 90
0
H - FID, where RD is a relaxation delay. The first 90
0
pulse excites all the nuclear spins: the second 900 pulse causes coher-
ence transfer between the magnetisations of hydrogens which are
spin-coupled to one another. The reason for the importance of the
COSY experiment can be best illustratedwith an example. If we observe
a methyl doublet signal in a urine sample at 1.34 ppm and that doublet
signal has a coupling constant of 6.9 Hz, we could infer that that signal
originated from lactic acid. However, if a 2D 1H COSY NMR spectrum
of that urine sample indicated that the methyl doublet at 1.34 ppm
was spin-coupled to a methyne proton at 4.13 ppm, that would be
much stronger evidence that the methyl signal was indeed from lactic
acid. The probability of known metabolite mis-identification decreases
strongly with each successive connected spin matched to the corre-
sponding signal in the spectrum of the authentic metabolite.
It is typical to run quick 2D 1H COSY NMR spectra with low digital
resolution and often low sensitivity. This can be appropriate for the
rapid analysis of pure chemical compounds but is not appropriate for
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metabonomics studies, as it results in the limited observation of
hydrogen-to-hydrogen connectivities for major metabolites over 2-
bonds or 3-bonds only. If the experiment is run at higher sensitivity
and resolution, much more information can be gleaned, from a larger
number of metabolites. Acquiring 2D COSY data at higher resolution
can cost time, but this would not be done for every sample in a large
metabonomics experiment. A high resolution COSY NMR spectrum
would only be obtained on a handful of samples that are representative
of the different groups in the study, with the express purpose of aiding
metabolite identification.
Using traditional methodology, a high resolution COSY spectrum
might take several hours to acquire. For example, Fig. 10 shows an ex-
pansion of the 600 MHz 2D 1H COSY NMR spectrum of the pooled
urine from two FMO5 KO mice [61] at 60 weeks age. This experiment
was acquired with spectral widths in f1 and f2 of 9578 Hz, and 4096
points in the FID (t2) for 512 values of the evolution time (t1): the
Fig. 7. The low frequency region of the 600MHz 2D 1H J-resolved NMR spectrum of the urine of a male, 30-week-old, FMO5 knockout mouse [61] displayed as a contour plot underneath
the corresponding 1D 1HNMR spectrum. The overlapping signals from the triplet methyl group ofN-butyrylglycine (0.926 ppm, three blue circles and downward arrows) and the doublet
methyl group of isovaleric acid (0.916 ppm, two red squares and upward arrows) are completely resolved in the 2D JRESNMR spectrum. The spectrum is tilted by450, so that all the signals
of each multiplet appear at the same chemical shift, and it is symmetrised.
Fig. 8. An expansion of the 600MHz 2D 1H J-resolved NMR spectrum of the urine of a male, 30-week-old, FMO5 knockoutmouse [61] in the region of the AB resonances from citric acid at
ca 2.70 and ca 2.56 ppm (four dots in 1D spectrum), displayed as a contour plot underneath the corresponding 1D 1HNMR spectrum. The spectrum is tilted by 450, so that all the signals of
eachmultiplet appear at the same chemical shift, and symmetrised. The signals labelledwith stars, appearing at ca 2.63 ppm, exactly in between the shifts of the two citrate signals are 2nd
order effects caused by themixing of transitions between theA andB spins by the 1800 pulse, in the presence of strong coupling. As is clear from the 1D 1HNMR spectrum, there are no real
signals at 2.63 ppm!
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final spectrum was an 8192 by 2048 data matrix. The acquisition time
was 0.428 s with a relaxation delay of 2 s, and 32 transients per incre-
ment of the evolution time, resulting in a total experiment time of just
over 11 h, which is a significant investment of time. However, that
additional time does allow correlations via small couplings over 4- to
6-bonds to be observed and these can be important formetabolite iden-
tification, as they enable connectivities to be established between parts
of molecular structures isolated by so-called ‘spectroscopically silent
centres’. These silent centres are atoms with no hydrogens attached or
no non-exchanging hydrogens. These spectroscopically silent centres
break up the chains of proton-to-proton connectivity in a metabolite
that are important for metabolite identification by e.g. COSY NMR. In
this case the silent centre is the pyridinium nitrogen, which has no hy-
drogens bonded to it.
When run at high resolution, the 2D 1H COSY NMR spectrum
can also be used to identify themultiplicity of signals that are complete-
ly buried in the 1D 1H NMR spectrum, and even those that are buried
in the 2D 1H JRES NMR spectrum. For example, the signal for the
C4H methyne proton of ketoleucine at 2.098 ppm was invisible in
the 1D 1H NMR spectrum (Fig. 11 top), or in the corresponding 2D 1H
Fig. 9. An expansion of the 600 MHz 2D 1H J-resolved NMR spectrum of the urine of a male, 30-week-old, FMO5 knockout mouse [61] in the region of the resonances from the C3
methylene hydrogens of 2S-hydroxyglutaric acid, displayed as a contour plot underneath the corresponding 1D 1H NMR spectrum. The spectrum is tilted by 450, so that all the signals
of each multiplet appear at the same chemical shift, and symmetrised. The peak picking allows a simple analysis of three of the four couplings that these hydrogens possess as 4.2, 6.3
and 10.5 Hz (2.003 ppm) and 5.5, 7.6 and 10.3 Hz (1.845 ppm). Note that these multiplets are invisible in the 1D 1H NMR spectrum.
Fig. 10. An expansion of the 600 MHz 2D 1H COSY NMR spectrum of the pooled urine of two male, 60-week-old, FMO5 knockout mice [61] in the region of the broad singlet methyl
resonances from trigonelline at ca 4.435 and 1-methylnicotinamide ca 4.475 ppm, displayed as a contour plot underneath the corresponding resolution-enhanced 1D 1H NMR
spectrum. Trigonelline displays cross-peaks due to long-range, 4-bond coupling from the methyl protons to the H2 (9.111) and H6 (8.820) protons ortho to the pyridinium nitrogen.
1-methylnicotinamide displays the same cross-peaks to H2 (9.259) and H6 (8.951), but in addition, displays a clear and remarkable cross-peak via six-bond coupling to H4 (8.883).
The ability to connect the methyl shift with the pyridinium proton shifts in this way can assist metabolite identification enormously.
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J-resolved NMR spectrum of the same sample (Fig. 9) but its identifica-
tion is confirmed from the high-resolution COSY spectrum (Fig. 11).
The C4H peak of ketoleucine is a triplet of septetswhich appears as a
pseudo-nonet, as the coupling from C4H to the C3H2 group (7.0 Hz) is
very similar to the spin-coupling to the six equivalent methyl group
protons (6.7 Hz). The two weak outside lines of the pseudo-nonet are
weak and difficult to observe even in the authentic reference standard
(BMRB, BMSE000383; HMDB00695 (caution the HMDB 1D 1H NMR
was run at pH 3! [accessed 12 September 2015]). The high resolution
COSY spectrum shown in Fig. 11 allowed the measurement of the fre-
quency separation of highest and lowest frequency lines observed in
the multiplet at 2.098 as 41.4 Hz, which corresponded well (COSY digi-
tal resolution in f2 = 0.73 Hz) to the separation in authentic material:
40.8 Hz in BMSE000383, thus providing further confidence for the as-
signment of this cross-peak.
The COSY experiment should always be run with good resolution in
the FID (t2) as that resolution is essentially ‘free’. The increase in the ac-
quisition time that this costs can be counterbalanced by a corresponding
decrease in the relaxation delay between successive transients. Increas-
ing the resolution across the second dimension, t1, does cost however,
as does increasing the number of transients per value of the evolution
time, and it is here that non-uniform sampling (NUS) methods and
FAST NMR methods may lead to decreases in acquisition times in 2D
NMR experiments for metabolite profiling in the future. Preliminary
studies show promise and we await developments in this area with in-
terest [64].
3.4. 2D 1H total correlation spectroscopy (TOCSY)
The 2D 1H TOCSY NMR experiment, sometimes called ‘homonuclear
Hartmann–Hahn spectroscopy’ (HOHAHA), is a relatively simple NMR
experiment often used in conjunctionwith the COSY experiment to elu-
cidate further structural information on smallmolecules of interest [65].
TOCSY provides similar information to a COSY experiment with
regards to directly coupled hydrogens, but provides further structural
information by identifying larger, interconnected groups of indirectly
spin-coupled hydrogens.
In comparison to the COSY sequence, the second 90°H pulse is re-
placed by a spin-lock field, applied for 10 s of milliseconds, which can
be considered to behave like a series of 180° H pulses. The spin-lock
field eliminates chemical shifts during its application, but does not affect
the scalar coupling. Due to the elimination of chemical shift differences
in the spin-lock period, the spins are in a strong coupling regime, lose
their individual identity and undergomagnetisation or coherence trans-
fer. The magnetisation transfer that takes place is governed by the
length of the spin-lock periods. Short spin-lock periods (20–100 ms)
yield cross peaks for directly coupled spins. With longer spin-lock
times (100–300 ms), coherence will be transferred more remotely
down chains of spin-coupled hydrogens. Thus, if we have a spin system
AMX, where A is coupled to M and M is coupled to X, but A is not
coupled to X, two situations can arise in the TOCSY experiment. For
short spin-lock periods, correlations will be seen between the chemical
shifts of both A and M and of M and X. For longer spin-lock periods,
cross-peaks will also be observed between A and X, even though they
are not directly coupled.
A good example of this can be shown in N-butyrylglycine
(HMDB00808) which has an alkyl chain three carbons long. In a
COSY experiment, the protons from the terminal C4-methyl group
(0.926 ppm)would only have cross peak correlations with the adjacent
C3-methylene protons (1.617 ppm). However, further structural in-
formation for N-butyrylglycine is provided (Fig. 12, see also Figs. 2
and 7) when a cross peak is observed at the resonance of the remote
C2-methylene protons (2.279 ppm).
A one-dimensional version of the TOCSY experiment is also avail-
able. The experiment involves the selective excitation of a signal follow-
ed immediately by the application of the spin-lock field to effect
coherence transfer, essentially observing a slice of a 2D TOCSY. Chemical
shift selective filter TOCSY (CSSF-TOCSY) uses excitation sculpting tech-
niques with pulse field gradients to selectively excite overlapping pro-
ton signals with tiny chemical shift differences, enabling reliable
extraction of coupling constants, important in metabolite identification.
Fig. 11. An expansion of the 600MHz 2D 1HCOSYNMR spectrum of the urine of amale, 30-week-old, FMO5 knockoutmouse [61] highlightingwith 7 arrows the cross-peak from the C4H
proton of ketoleucine (structure inset) at 2.098 to the equivalent C5 and C6 methyl groups at 0.941 ppm. The signals from ketoleucine at 2.098 are not visible either in the 1D 1H NMR
spectrum (top), or in the 2D 1H J-resolved NMR spectrum of the same sample (see Fig. 9) but the identification is confirmed from this high-resolution COSY spectrum. The seven cross
peaks marked are the most intense peaks of the 9-line, pseudo-nonet, triplet of septets, the two outside lines of which are too weak to observe. See text for details.
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3.5. 2D 13C, 1H Heteronuclear Single Quantum Correlation (HSQC) NMR
spectroscopy
The 2D 13C, 1H Heteronuclear Single Quantum Correlation (HSQC)
NMR Spectroscopy experiment is another fundamental experiment for
metabolite identification. The experiment operates by correlating the
chemical shifts of hydrogens with the chemical shifts of carbon-13 nu-
clei to which they are directly attached via 1JC,H. The reason that this ex-
periment is important is two-fold. Firstly, it introduces a completely
new and orthogonal dimension beyond 1H NMR to obtain information
on the structure of metabolites: that available from the C-13 NMR
chemical shift. Secondly, the chemical shifts of the carbon-13 nucleus
extend over about 220 ppm for most metabolites: this is ca 20 times
the range of proton NMR chemical shifts (ca 11 ppm), and these 13C
NMR shifts thus provide a much more sensitive response to minor
changes in metabolite structure than does the 1H NMR chemical shift:
see Section 2.2.
Many variants of the 2D 13C, 1H HSQC NMR experiment are in cur-
rent usage [35] and its successful execution does have some challenges.
All variants of this experiment use 1H detection for high sensitivity and
thus, not only must the enormous proton signals from water be sup-
pressed, but also all of the signals from hydrogen atoms that are
bound to carbon-12 nuclei, which is 99% of the hydrogens in each me-
tabolite. Fortunately, the availability of high performance digital NMR
spectrometers and gradient pulses has made the experiment routine.
Indeed, new variants suitable for metabolite profiling in biofluids are
now available that even provide carbon multiplicity editing as well. In
these experiments, the 2D 13C, 1H HSQC NMR spectrum not only dis-
plays the cross-peaks due to 1JC,H correlations, but also edits the cross-
peaks in a phase-sensitive fashion so that the cross-peaks due tomethyl
(CH3) and methyne (CH) moieties are of opposite phase to those of
methylene groups (CH2). This provides tremendous power for the as-
signment of signals in crowded regions of the 1H NMR spectra of a
biofluid: see Fig. 13.
The multiplicity-edited, 2D 13C, 1H HSQC NMR spectrum in Fig. 13,
readily distinguishes the red, positive cross-peaks (asterisked) arising
from the methyl groups of creatinine (3.04, 32.98), creatine (3.04,
39.71) and dimethylamine (2.73, 37.36) from the blue, negative cross-
peaks (no asterisks) due to the methylene groups in cis-aconitic acid
(3.14, 46.34), 2-ketoglutaric acid (3.02, 38.63 and 2.45, 33.41) and
succinic acid (2.42, 36.79). This experiment is a tremendous aid to the
correct assignment of complex biofluid NMR spectra.
3.6. 2D 13C, 1H Heteronuclear Multiple Bond Correlation (HMBC) NMR
spectroscopy
The 2D 13C, 1H Heteronuclear Multiple Correlation (HMBC) NMR
Spectroscopy experiment [35] is another critical experiment in the
identification of metabolites using NMR methods. The key reason for
its importance is that it enables the establishing of connectivities be-
tween the parts of a metabolite's structure that are separated from
one another by quaternary carbons or heteroatoms with no slow-
exchanging, attached hydrogens. These are the so-called ‘spectroscopi-
cally silent centres’ mentioned earlier. The problem is that these silent
centres interrupt the chains of proton-to-proton connectivity between
regions of protonated carbons, resulting in isolated fragments of struc-
ture that may not be easy to piece together. To take a simple example,
in the molecules cis- and trans-aconitic acid, the methylene moiety is
separated from the olefinic proton by a quaternary carbon. In this case
theHMBC experiment can help to connect the two fragments of proton-
ated carbon structure together by establishing connectivities between
hydrogens and carbon separated by two or three bonds (Fig. 14).
The HMBC experiment is critical for establishing connectivities be-
tween regions of protonated carbon structure when they are separated
by quaternary carbons or heteroatoms. Although relatively insensitive,
the HMBC experiment is sometimes the only way to obtain this infor-
mation, if it is not available from alternatives such as high resolution
COSY.
Fig. 12.Anexpansion of the 600MHz 2D 1HTOCSYNMR spectrumof the urine of a 30-week-oldmale C57BL/6mouse. The cross peaksmarked originate from the alkyl chain connectivities
ofN-butyrylglycine, from the terminalmethyl group (C4). The cross peakmarked at 0.926, 1.617 ppm represents a direct correlation from the C4methyl protons to the adjacent C3meth-
ylene group, equivalent to the cross-peak thatwould be observed in a 2D 1HCOSYexperiment. Additionalmetabolite identification information is provided in this TOCSYexperimenthow-
ever,with the cross-peak at 0.926, 2.279 ppmestablishing a connection between theC4methyl protons and the C2methylene group, even though there is no observable coupling between
them.
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4. Metabolite identification
In this section we will bring together information obtained from 1D
and 2D NMR experiments, together with information from metabolite
databases and other sources to achieve metabolite identification and
we will review methods for assessing the confidence in those metabo-
lite identifications. There are essentially three strands to this activity:
1) the use of statistical methods to determine which NMR signals in a
particular study are statistically significantly discriminating between
groups of subjects in the study, or otherwise important, and therefore
require identification and assignment, 2) the structure elucidation of
novel metabolites, not previously described and 3) the structure confir-
mation of known metabolites. Some authors [28,66] have described
novel metabolites as unknown unknowns and known metabolites as
Fig. 13.Anexpansion of the 600MHz,multiplicity-edited, 2D 13C, 1HHSQCNMR spectrumof the pooled urine of 60-week-old,male, FMO5 knockoutmice [61], displayed as a contour plot
underneath the corresponding resolution-enhanced 1D 1HNMR spectrum. In this phase-sensitive plot, positive peaks are represented by red contours (asterisked) and negative peaks by
blue contours (no asterisks). See text for further explanation.
Fig. 14. An expansion of the 600 MHz 2D 13C, 1H HMBC NMR spectrum of the pooled urine of male, 60-week-old, FMO5 knockout mice [61], displayed as a contour plot underneath the
corresponding resolution-enhanced 1D 1H NMR spectrum in the region of the signals from the methylene protons of cis-aconitic acid (3.14) and trans-aconitic acid (3.47 ppm). The
methylene protons display all four possible 2- and 3-bond hydrogen-to-carbon connectivities, to both adjacent carboxylic acid carbons (178.8, 182.4 ppm, trans- and 179.1 and
181.7 ppm, cis-isomer) plus connections to the quaternary and protonated olefinic carbons at 141.6 and 133.9 (trans-) and 146.3 and 127.6 ppm (cis-isomer), respectively, thus
establishing connectivities between the two regions of protonated carbon structure isolated from each other by the quaternary olefinic carbon.
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knownunknowns, but this language is confusing and unhelpful:wewill
retain the clear and simple distinction between novel metabolite struc-
ture elucidation and known metabolite structure confirmation or identi-
fication, that has been used in molecular structure studies by NMR
spectroscopy for decades.
4.1. Identification of significant metabolites, or biomarkers, using multivar-
iate statistics
The main objective in metabonomics is to extract relevant informa-
tion from the large multivariate data sets. To this end pattern recogni-
tion (PR) and related multivariate statistical approaches can be used
to discern meaningful patterns and identify metabolic signatures in
the complex data sets that are of diagnostic or other classification
value. A wide range of statistical methods is available today ranging
from unsupervised methods, such as, principal component analysis
(PCA), [67] or hierarchical clustering (HCA) [68], to supervised ap-
proaches like partial least squares (PLS) [69], partial least squares dis-
criminant analysis (PLS-DA) and orthogonal partial least squares
discriminant analysis (OPLS-DA) [70].
PCA is the most common technique in multivariate analysis that re-
duces the dimensionality of data and provides an unbiased overview of
the variability in a dataset. In this approach samples are clustered based
on their inherent similarity/dissimilarity with no prior knowledge of
class membership. PCA represents most of the variance within a data
set using a smaller set of variables, so-called principal components
(PCs). Each PC is aweighted linear combination of the original variables,
and each consecutive PC is orthogonal to the previous PC and describes
the maximum additional variation in the data set that is not accounted
for by the previous PCs. The results of a PCA are generally reported in
terms of component scores, and loadings. In a scores plot, each point
corresponds to a sample spectrum. Scores plots provide an overview
of all samples and enable the visualisation of groupings, trends and out-
liers. A loadings plot illustrateswhich variables have the greatest contri-
bution to the positioning of the samples on the scores plot and are
therefore responsible for any observed clustering of samples. Since di-
rections in the scores plot correspond to directions in the loadings
plot, an examination of the loadings can explain spectral clustering ob-
served on the scores plot [71–73]. Usually, PCA constitutes the first step
in metabonomic data analysis and is commonly followed by supervised
pattern recognition techniques. Thesemethods use class information of
the samples to maximise the separation between different groups of
samples and detect the metabolic signatures that contribute to the
classifications.
One commonly used supervised method is partial least squares, also
known as projection to latent structures (PLS), which links a datamatrix
of predictors usually comprising spectral intensity values (an Xmatrix),
to a matrix of responses containing quantitative values (a Y matrix).
When the response matrix is categorical, i.e. the Ymatrix contains sam-
ple class membership information, the application of PLS regression is
called partial least squares-discriminant analysis (PLS-DA). PLS has
also been used in combination with a pre-processing filter termed or-
thogonal signal correction (OSC), which excludes irrelevant parts of
the data that are uncorrelated (orthogonal) with the response, often
referred to as structured noise. This structured noise in the data set
can be caused by analytical variation or by innate physiological variation
(e.g. different diet, age, gender). Orthogonal partial least squares dis-
criminant analysis (O-PLS-DA) has an advantage over the standard
PLS because it filters the irrelevant variation and hence enhances the
model interpretation and identification of important variables that are
responsible for the observed classification [73–75]. Recently, a more
advanced statistical technique, Statistical HOmogeneous Cluster
SpectroscopY (SHOCSY), has been developed which can better address
irrelevant variation in datasets and enhance the interpretation and pre-
dictive ability of the OPLS-DAmodel via the selection of ‘truly’ represen-
tative samples in each biological class [76].
In supervised techniques, loading weight, variable importance on
projection (VIP) and regression coefficient plots are used to determine
the most significant discriminating variables. Recently, a new approach
has been introduced by Cloarec et al. that incorporates the back-
transformed loading of an auto-scaled model with the respective
weight of each variable in the same plot. The resulting loading plot cre-
ated in this way has the same shape as that of a spectrum with colour-
coded coefficients, according to statistical significance for each variable,
which allows for easier interpretation of chemometric models [77].
Generally, supervised techniques are subject to overfitting, particu-
larly in metabonomic studies where the number of variables is large
and therefore the chance of false correlations is high. Proper model val-
idation is therefore a key step to ensure model reliability and identifica-
tion of true biomarkers. There are various validation methods including
k-fold cross validation, permutation and test set validation. [78–81]
Cross validation is performed in most cases, especially when the num-
ber of samples is low. Here, the k subset of samples is iteratively left
out and predicted back into the model until all samples have been
used once. However, truly robust model validation is achieved by divid-
ing the data into a training set and a test set. The training set is used to
construct a model and the test set is used to assess the model
performance.
4.2. Statistical Correlation Spectroscopy (STOCSY) for metabolite
identification
Statistical Correlation Spectroscopy (STOCSY) follows the concept of
two dimensional correlation spectroscopy which had originally been
implemented in other spectroscopic techniques including fluorescence
and Raman spectroscopies [82]. The development and adaptation of
STOCSY in NMR spectra was initially performed by Cloarec et al. and is
traditionally applied to one dimensional 1HNMR [74]. STOCSY takes ad-
vantage of the inherently linear relationship between intensity
variables belonging to the same molecule in an NMR spectrum. It anal-
yses the covariance of variables in a series of spectra and produces a cor-
relation matrix, presented in the form of an NMR spectrum, which
reveals the degree of correlation between each variable in the spectrum
(either one-dimensional or two-dimensional; see Fig. 15). Depending
on the strength of the correlation, correlated variables or resonances
(consisting of many variables depending on the resolution) might be-
long to the same molecule (strong correlation) or molecules in the
same metabolic pathway (weaker correlation). The correlation of each
resonance, relative to the selected peak on which STOCSY is performed,
is revealed by a colour scale which ranges from low correlation (typical-
ly 0) to high correlation (typically 1) [74]. In the field of metabonomics
this technique is particularly useful in the analysis of complex mixtures,
such as urine, where the identification of metabolites can be difficult
due to the high density of resonances and potential overlapping [74].
It is important to clarify that the ability of STOCSY to detect the cor-
rect correlations is affected by the degree of overlap between reso-
nances, as well as low concentrations. Significant overlapping with
other peakswill distort the covariance of different resonances belonging
to the same molecule in a spectrum, whilst resonances closer to the
noise level are harder to analyse. Such deficiencies have led to the devel-
opment of other techniques including SubseT Optimization by Refer-
ence Matching (STORM), which uses an iterative method to calculate
the correlations and is better suited to dealing with potential overlaps
or low concentrations [13].
4.3. Structure elucidation of novel metabolites
If a truly novel metabolite is identified in the course of a
metabonomics study, then a full structure elucidation to the standard
generally accepted for the identification of novel natural products [83]
or novel drug degradation products [84] is required. This will usually
entail the isolation and purification of the novel metabolite from
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the biofluid and a full structure elucidation, typically using NMR spec-
troscopy, MS, infrared spectroscopy and ultraviolet spectroscopy, and /
or the synthesis of the metabolite for direct comparison with the data
obtained from the biofluid.
4.4. Use of information from metabolite databases
Most metabolites observed by NMR spectroscopy in metabonomics
studieswill be known, and information on a proportion of these is avail-
able in various databases such as the Human Metabolome Database
(HMDB) [45], the BioMagResBank (BMRB) [85] and the Birmingham
Metabolite Library (BML) [86]. The HMDB is the largest repository of
NMR and MS data on human metabolites that is currently available. As
of September 4th 2015, the HMDB contained information on 41,993
metabolites. However, only 1381 of thesemetabolites have experimen-
tal NMR data, totalling 3186 NMR spectra. Thus, there are manymetab-
olites for which it is not currently possible to access NMR data online.
Databases such as the HMDB are valuable for fourmain reasons: 1) pro-
vide search facilities that allow the identification of known metabolites
based on matches between user spectral data and database data on au-
thentic metabolite samples, 2) provide interpreted 1D 1H and 2D NMR
spectra (particularly 2D 13C, 1HHSQC spectra)ofmetabolites; 3)provide
access to the raw free induction decay data for authenticmetabolites for
downloading, processing and comparisonwith user data onmetabolites
from biofluids and 4) provide metadata on the metabolites and links to
other databases.
The 2D 13C, 1H HSQC search facility in the HMDB is particularly use-
ful, as it uses both 1H and 13C NMR chemical shift information, and
searches for matches between HSQC cross-peak coordinates input by a
user and those of authentic metabolites in the database. This is a good
place to start a metabolite identification exercise. The user must input
the tolerances for the chemical shift differences between the user
input values and database values:metaboliteswhose cross-peak coordi-
nates are inside those tolerances will be returned as ‘candidatemetabo-
lites’. Chemical shifts will naturally be different between those of an
authentic sample in water, D2O or phosphate buffer and those of the
same metabolite in a biofluid such as urine or plasma, but generally
1H NMR chemical shifts should agree to +/−0.03 ppm and 13C NMR
chemical shifts to +/−0.5 ppm. These differences will increase for 1H
or 13CNMRchemical shifts inmetaboliteswhich can undergo tautomer-
ism [87] of any kind and the shift differences may also be larger for nu-
clei close to ionisable groups in metabolites: both these features will be
sensitive to environment.
When reviewing the candidate structures returned by the database
that have HSQC features matching the user query, other information
about the metabolite of interest will be used to discriminate the candi-
dates. This information could include the multiplicity in the 1H NMR
spectrum of the hydrogen giving rise to the HSQC signal, or connectivity
information linking further elements of the metabolite structure from
COSY or HMBC spectra. Of course, if the database search is done on
just one HSQC cross-peak observed in the spectrum of the biofluid,
ALL remaining HSQC cross-peaks in that metabolite should also be ob-
servable in the biofluid HSQC spectrum, and the absence of any of the
expected HSQC cross-peaks would put a question mark over the identi-
fication of the metabolite. On the other hand, as seen above, even data-
bases as large as the HMDB are incomplete and searches will return no
candidate structures for known metabolites if: (i) the metabolite is not
entered into the database, (ii) the metabolite is in the database but the
relevant NMR data is not, or (iii) the metabolite is in the database but
the relevant NMR data is not correctly entered.
A further caveat to the use of metabolite databases is that they are
only as good as the quality of the data entered into them.Usersmust be-
ware that errors of several type are present at a low level in current da-
tabases such as the HMDB, including incorrect samples, incorrect
structures for the metabolites, impure samples and incorrect assign-
ments. A good approach is to always download the original data and
check it against expectations, and/or check the values given across
more than one database where possible.
4.5. Prediction of NMR spectra of metabolites for structure confirmation
An ideal situation for the confident identification of known or novel
metabolites would be to be able to predict their NMR spectra computa-
tionally without the need for access to authentic, real samples. In
Section 2.2, we saw that 13C NMR chemical shifts could be predicted
by hand for simple molecules. Accurate chemical shift prediction
would allow the expansion of databases such as the HMDB to include
all known metabolites and the confident identification of novel as well
as known metabolites. At present, this approach is not generally possi-
ble. Software such asMNova [46] andMarvin [47] allows the prediction
of 1H and 13C NMR spectra. In our experience, these approaches are use-
ful and somewhat successful but may fail in cases where themetabolite
structure is complex, or is complicated by tautomerism ormultiple sites
of ionisation, and the methodology cannot always compute these with
confidence for the relevant biological matrix.
4.6. Biochemical transformation and in vitro fermentation of biofluids to aid
metabolite identification
One successful approach tometabolite identification that is current-
ly under-utilised is the biochemical transformation of unknownmetab-
olite A in a biofluid to known metabolite B. This approach was used in
the identification of para-cresol sulphate (PCS) as the key biomarker
in human urine for the prediction of the metabolic fate of paracetamol
Fig. 15. NMR plot following a STOCSY analysis on a set of faecal water 1H NMR spectra. The selected driver peak at 1.57 ppm was used to calculate the correlation matrix which reveals
correlations ranging from 0 (low) to 1 (high). Two other resonances were revealed to have a positive correlation of 1, suggesting that they arise from the same molecule that was later
identified as butyric acid.
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[5]. Incubation of samples of the human urine containing PCS with a
sulphatase enzyme led to the transformation of PCS to the known me-
tabolite para-cresol, which was then readily identified in this first
human pharmacometabonomics study.
Amore extreme andmore random, but still useful, implementation of
this approach can occur if biofluids are left at room temperature for ex-
tended periods of time. Biofluids such as mouse urine will quite likely
have been in contact with faecal material and thereby be contaminated
with bacteria from the animal's microbiome. It is standard practice in
metabonomics studies to add a low concentration of an anti-bacterial
agent such as sodium azide to animal urine samples to inhibit bacterial
growth, but unless the concentration of azide is high, bacterial growth
may still occur. This will cause in vitro fermentation in the urine and
will transform largenumbers ofmetabolites into different but relatedme-
tabolite products. For instance, bacterial fermentation in a sample of urine
from amale FMO5KOmouse at age 30weeks, led to the 100% conversion
of hippuric acid (benzoylglycine) to benzoic acid and glycine (Fig. 16).
Compared with single enzymatic transformations, the in vitro fer-
mentation approach is less specific. However, it is still a potentially use-
ful tool to clarify metabolite identifications, by transforming unknown
metabolites into known metabolites, or just to decrease crowding in a
particular spectral region.
4.7. Confidence levels in known metabolite identification and confirmation
of known metabolite identity
The Metabolomics Standards Initiative recognises 4 levels of known
metabolite identification:
Level 1: Identified Compound: A minimum of two independent and orthogonal
data (such as retention time and mass spectrum) compared directly relative to
an authentic reference standard
Level 2: Putatively Annotated Compound: Compound identified by analysis of
spectral data and/or similarity to data in a public database but without direct
comparison to a reference standard as for Level 1
Level 3: Putatively Characterised Compound Class: unidentified per se but the data
available allows the metabolite to be placed in a compound class
Level 4: Unknown Compound: unidentified or unclassified but characterised by
spectral data
These categorisations are somewhat vague in terms of the degree of
fit between the data on the metabolite and that on the reference stan-
dard it is being compared to. They have not been widely adopted
since their publication in 2007 [88,89], and this has been commented
upon recently [90]. Various modifications to the original categorisations
have been suggested [91,92] in order to improve them but with no gen-
eral agreement on the way forward. A call to the community was made
for engagement with this problem [91]. Encouragingly, a new, quantita-
tive Bayesian method for annotation of metabolites in LC–MS
experiments has recently emerged. [93] New quantitative NMR
spectroscopy-based proposals have also been published [94] that reject
the notion that knownmetabolite identification (as opposed to putative
annotation (Level 2)) must always be based on a direct comparison of
the experimental data on themetabolite in a biofluidwith that of an au-
thentic reference standard (Level 1 above). The newmethods are based
on the matching of information obtained experimentally from NMR
studies of biofluids with that contained on authentic metabolites in da-
tabases such as the HMDB. These methods analyse the amount of
matching 1D and 2D 1H NMR spectroscopic information obtained on
each metabolite, relative to the number of carbon atoms or heavy
atoms in the molecule. One promising new approach is called Metabo-
lite Identification Carbon Efficiency (MICE) [94] and provides a logical,
quantitative and systematic method for assessing confidence in
known metabolite identification by NMR methods.
The use of metabolite database information, as opposed to informa-
tion directly from the actual reference standards, to underpin metabo-
lite identification is appropriate for NMR spectroscopy-based methods.
In general, there is very good agreement between the chemical shifts
of a metabolite in a buffered biological fluid such as urine and in a
pure buffer solution of the same metabolite at the same pH. As men-
tioned in Section 4.4 above, generally, 1H NMR chemical shifts should
agree to +/−0.03 ppm and 13C NMR chemical shifts to +/−0.5 ppm
for most metabolites, although there will be cases of metabolites with
Fig. 16.Anexpansion of the 600MHz 1HNMR spectra of the urine of amale, 30-week-old, FMO5 knockoutmouse [61]: 1) before bacterial fermentation and 2) after bacterial fermentation
after leaving the sample at ambient temperature for several days. The bacterial fermentation causedmanymetabolic transformations including that of hippuric acid (hipp) to benzoic acid
(b.a.) and glycine (3.57 ppm, not shown) and the formation of formate. The lower spectrum1) prior to fermentation showsmany signals including those from the ortho (7.84), para (7.64)
andmeta (7.56) protons of hippuric acid, whereas post-fermentation, spectrum 2) at top, shows corresponding signals from the ortho (7.88), para (7.56) andmeta (7.49 ppm) protons of
benzoic acid.
150 A.C. Dona et al. / Computational and Structural Biotechnology Journal 14 (2016) 135–153
greater chemical shift sensitivity, due to the arrangement of ionisable
groups in their molecular structures, for instance, citric acid. There will
be an even closer agreement between the chemical shifts of a reference
standard run in similar buffers between one laboratory and the next.
Therefore access to the NMR spectral data on a metabolite from a data-
base such as HMDB is, in most cases, equivalent to having run the NMR
spectrum of thatmaterial under the same conditions in the user labora-
tory. It must be stressed however, that all database data should be
checked for quality and for matching to the expected structure. Mis-
takes in databases do occur: users should be aware. On the other
hand, for MS-based metabonomics approaches, such as LC–MS or
UPLC–MS, the use of authentic reference standards is more important,
due to variations in metabolite retention times and peak intensities
that can occur in these experiments, although newmethods aremaking
the metabolite annotations more secure [93].
The MICE method mentioned above is one of many new variants
that can be used for the assessment of known metabolite identification
confidence. In its recommended HSQC-level implementation [94], MICE
counts and sums the number of bits of spectroscopic identification in-
formation obtained from 1H NMR chemical shifts, multiplicities, cou-
pling constants, second-order flags (flag = 0 if metabolite signals are
first order; flag = 1 if signals second-order [strict definition: additional
lines present in the spectra]), 2D COSY cross-peaks and 2D HSQC cross
peaks, for each metabolite, that match corresponding database values
for the authentic metabolite. The MICE value is then obtained by divid-
ing this information bit sum total by the number of carbon atoms in the
metabolite. For example, the following signal features were observed
for the metabolite ketoleucine, (4-methyl-2-oxopentanoic acid,
HMDB00695, see Fig. 11 and structure below), in the 600 MHz 1H
NMR spectra of the urine of a male, 30-week-old FMO5 knockout
mouse [61]: a doublet (3JH,H ca 7.0 Hz) for the H3 protons at 2.618
with a COSY to 2.098 (triplet of septets, H4), itself with a COSY to the
equivalent methyl groups H5, and H6 at 0.941 (doublet, 6.7 Hz) and
these with an HSQC to 24.5 ppm (C5, C6). Thus for this metabolite, we
observed 3 1H NMR chemical shifts, 3 multiplicities, two coupling con-
stants, two COSY connectivities and one HSQC connectivity: a total of
11 pieces of information, all of which are a good match to the corre-
sponding values in the HMDB. The guidelines for a good match are:
within ±0.03 ppm for 1H, and ±0.5 ppm for 13C NMR shifts and
±0.2Hz for proton couplings. There are 6 carbon atoms in themolecule,
so theMetabolite Identification Carbon Efficiency (MICE)= 11/6= 1.8.
MICE values of N1with a goodmatch of spectral features to those of the
standard in a database are considered confidently identified, as in this
case.
Even if a known metabolite is confidently identified by NMR spec-
troscopy using the MICE methodology, it can sometimes still be impor-
tant to further confirm the identification, especially if the particular
metabolite is an important biomarker. Three basic approaches are fre-
quently used: 1) authentic metabolite spiking; 2) orthogonal analyses
using MS-based approaches and 3) isolation or purification of the me-
tabolite using chromatographic procedures.Metabolite spiking involves
the addition of a small quantity of an authentic sample of themetabolite
into the biofluid of interest and re-running the NMR spectrum. If the
metabolite is present in the biofluid, then the signals of the spiked ma-
terial should overlap exactly with those assigned to that metabolite in
the original biofluid. For this experiment to work well, spectral resolu-
tion and lineshape must be optimal and it is best to spike in a quantity
equalling between 25% and 50% of thematerial in the biofluid: too little
material spiked can lead to uncertainty as to whether the signals of in-
terest have increased in intensity: too much material spiked may
swamp the signals and lead to uncertainty as to whether the spike
signals match those of the metabolite of interest. Liquid chromatogra-
phy–mass spectrometry (LC–MS) or ultra performance liquid chroma-
tography MS (UPLC-MS) [29,30] is often used as an orthogonal
confirmatory technique for metabolites identified by NMR spectrosco-
py. This joint NMR and MS approach will provide the maximal confi-
dence in the identification of known biomarkers that are particularly
important. Isolation or purification procedures may use liquid chroma-
tography, solid-phase extraction or liquid–liquid extraction methods
[95,96].
5. Conclusions and future thoughts
Metabonomics/metabolomics is undergoing a period of very rapid
technology development and a huge increase in the number of applica-
tions, using mainly NMR spectroscopy or MS detection technologies. In
this guide, we have focused upon themetabolite identification stage of a
project using NMR spectroscopy-based detection of metabolites.
Compared with MS, NMR spectroscopy is much less sensitive, but has
the key advantages of better spectrometer stability, absence of spec-
trum quenching or enhancement phenomena, full quantitation of me-
tabolites and the ability to use a huge range of the most powerful
experiments for metabolite structure elucidation. NMR-detected
metabonomics/metabolomics has been delivering answers to impor-
tant questions in medicine, biology and other sciences for over
30 years andwe confidently predict that it will continue to do so for de-
cades more.
Many key advances in NMR spectroscopy-based metabonomics are
emerging and these are expected have a significant impact on the utility
of the technology. We can highlight the following: 1) the development
of highly stable digital spectrometers producing spectra of unparalleled
quality; 2) the development of probes with multiple receiver coils en-
abling the parallelisation of some data acquisition; [97] 3) the develop-
ment of non-uniform sampling and spatially-encoded ‘ultrafast’
methods [64] of 2D NMR data acquisition, which hold out the prospect
that in the future the default metabonomics experiment may be 2D
COSY or 2D J-resolved rather than the current standard: 1D 1H NMR;
4) huge advances in the computational analysis of NMRdata inmethods
derived from STOCSY that hold out the prospect of a systems biology
analysis directly from the NMR data [98] and finally 5) the use of reli-
able, chilled, NMR sample automation systems which mean that large-
scale experiments on hundreds or thousands of samples are feasible, en-
abling the advent of large-scale phenome analyses [12]. We await this
future with excitement and much anticipation.
Glossary of terms
Term Meaning
1D one-dimensional
2D two-dimensional
900H a 90 degree pulse to the
1H channel
1800H a 180 degree pulse to the
1H channel
BML Birmingham Metabolite Library
BMRB BioMagResBank
CAWG Chemical Analysis Working Group
COSY COrrelation SpectroscopY
CPMG Carr–Purcell–Meiboom–Gill
CSSF-TOCSY Chemical Shift Selective Filter TOCSY
δH
1H, hydrogen-1 or proton NMR chemical shift
δC
13C or carbon-13 NMR chemical shift
FID Free Induction Decay
FMO5 Flavin Mono-Oxygenase 5
(continued on next page)
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(continued)
Term Meaning
GC–MS Gas Chromatography–Mass Spectrometry
HCA Hierarchical Cluster Analysis
HMBC Heteronuclear Multiple Bond Correlation spectroscopy
HMDB Human Metabolome DataBase
HOHAHA HOmonuclear HArtman HAhn
HSQC Heteronuclear Single Quantum Correlation spectroscopy
ID identification
3JH,H three-bond spin–spin coupling between two hydrogens
JRES J-resolved spectroscopy
KO gene Knock Out
LC–MS Liquid Chromatography-Mass Spectrometry
MHz MegaHertz = Hertz x 106
MICE Metabolite Identification Carbon Efficiency
MS Mass Spectrometry
MSI Metabolomics Standards Initiative
NOESY nuclear Overhauser enhancement spectroscopy
NMR Nuclear Magnetic Resonance
O-PLS-DA Orthogonal-Partial Least Squares-Discriminant Analysis
PC Principal Component
PCA Principal Components Analysis
PLS Partial Least Squares (Projection to Latent Structures)
RD Relaxation Delay
SHOCSY Statistical HOmogeneous Cluster SpectroscopY
STOCSY Statistical TOtal Correlation SpectroscopY
STORM SubseT Optimization by Reference Matching
t1 evolution time in a 2D NMR experiment
t2 the acquisition time over which the FID is measured
T1 spin–lattice relaxation time
T2* real spin–spin relaxation time
TOCSY TOtal Correlation SpectroscopY
TSP sodium 3-(trimethylsilyl) propionate-2, 2, 3, 3-d4
UPLC–MS Ultra-Performance Liquid Chromatography Mass Spectrometry
VIP Variable Importance on Projection
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